Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Sitges, María ^a   Gómez, Carlos D ^a   Aldana, Blanca I ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PENTETRAZOLE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; AUTACOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; LOW DRUG DOSE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SEIZURE; SINGLE DRUG DOSE; TONIC CLONIC SEIZURE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SEIZURES;

RATTUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; PENTYLENETETRAZOLE; RATS; RNA, MESSENGER; SEIZURES; SERTRALINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84909606645     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111665     Document Type: Article

References (38)

1. Danzer SC (2011) Depression, stress, epilepsy and adult neurogenesis. Exp Neurol 233: 22-32.
2. Kanner AM (2008) Depression in epilepsy: a complex relation with unexpected consequences. Curr Opin Neurol 21: 190-194.
3. Kanner AM, Trimble M, Schmitz B (2010) Postictal affective episodes. Epilepsy Behav 19: 156-158.
4. Mula M (2012) Epilepsy: Bidirectional link between epilepsy and psychiatric disorders. Nat Rev Neurol 8: 252-253.
5. Noe KH, Locke DE, Sirven JI (2011) Treatment of Depression in Patients with Epilepsy. Curr Treat Options Neurol 13: 371-379.
6. Stevanovic D, Jancic J, Lakic A (2011) The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 52: e75-e78.
7. Tellez-Zenteno JF, Patten SB, Jetté N, Williams J, Wiebe S (2007) Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48: 2336-2344.
8. Maes M (1993) A review on the acute phase response in major depression. Rev Neurosci 4: 407-416.
9. Maes M (1995) Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 19: 11-38.
10. Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35: 298-306.
11. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, et al. (2010) A metaanalysis of cytokines in major depression. Biol Psychiatry 67: 446-457.
12. Howren MB, Lamkin DM, Suls J (2009) Associations of depression with Creactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171-186.
13. Liu Y, Ho RC, Mak A (2011) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 139: 230-239.
14. De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, et al. (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12: 2623-2633.
15. Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ (2005) Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57: 152-155.
16. Plata-Salaman CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, et al. (2000) Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res 75: 248-258.
17. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, et al. (2008) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29: 142-160.
18. Sinha S, Patil SA, Jayalekshmy V, Satishchandra P (2008) Do cytokines have any role in epilepsy? Epilepsy Res 82: 171-176.
19. Vezzani A, Balosso S, Ravizza T (2008) The role of cytokines in the pathophysiology of epilepsy. Brain Behav Immun 22: 797-803.
20. Vezzani A, Friedman A, Dingledine RJ (2013) The role of inflammation in epileptogenesis. Neuropharmacology 69: 16-24.
21. Sheehan DV, Kamijima K (2009) An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. Int Clin Psychopharmacol 24: 43-60.
22. Aldana BI, Sitges M (2012) Sertraline inhibits presynaptic Na+ channelmediated responses in hippocampus-isolated nerve endings. J Neurochem 121, 197-205.
23. Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, et al. (2012) A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun 26: 469-479.
24. Black JA, Liu S, Waxman SG (2009) Sodium channel activity modulates multiple functions in microglia. Glia 57: 1072-1081.
25. Sitges M, Aldana BI, Gomez CD, Nekrassov V (2012) The antidepressant sertraline prevents the behavioral and EEG changes induced in two animal models of seizures. Epilepsy Behav 25: 511-516.
26. Tremaine LM, Welch WM, Ronfeld RA (1989) Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. Drug Metab Dispos 17: 542-550.
27. Janssen DG, Caniato RN, Verster JC, Baune BT (2010) A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol 25: 201-215.
28. Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36: 764-785.
29. Walker FR (2013) A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression? Neuropharmacology 67: 304-317.
30. Hamid H, Kanner AM (2013) Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs? Epilepsy Behav 26: 261-265.
31. Galvan E, Sitges M (2004) Characterization of the participation of sodium channels on the rise in Na+ induced by 4-aminopyridine (4-AP) in synaptosomes. Neurochem Res 29: 347-355.
32. Sitges M, Sanchez-Tafolla BM, Chiu LM, Aldana BI, Guarneros A (2011) Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs. Epilepsy Res 98: 257-288.
33. Huang RQ, Bell-Horner CL, Dibas MI, Covey DF, Drewe JA, et al. (2001) Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action. J Pharmacol Exp Ther 298: 986-995.
34. Macdonald RL, Barker JL (1977) Pentylenetetrazol and penicillin are selective antagonists of GABA-mediated post-synaptic inhibition in cultured mammalian neurones. Nature 267: 720-721.
35. Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a metaanalysis. Neuropsychopharmacology 36: 2452-2459.
36. Fieschi C, Lenzi GL, Zanette E, Orzi F, Passero S (1980) Effects on EEG of the osmotic opening of the blood-brain barrier in rats. Life Sci 27: 239-243.
37. Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, et al. (2007) Seizurepromoting effect of blood-brain barrier disruption. Epilepsia 48: 732-742.
38. Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, et al. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33: 171-181.